GeminIQ Website Logo

Viewing LNTH free

Subscribe for full history, 50+ metrics, screener, watchlist...

Lantheus Holdings, Inc.

LNTH

Companies in In Vitro & In Vivo Diagnostic Substances

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
499359382696939913866757718714614414
Accounts Receivable Net Current
356359351337349321329372337284259256
Inventory Net
616562626968717170645652
Income Taxes Receivable
11532--8------
Other Assets Current
252121346716222416171123
Assets Of Disposal Group Including Discontinued Op…
0817773-0777777
Assets Current
9429009251,2021,4241,3271,2961,2311,1491,086948752
Equity Securities Fv Ni And Without Readily Determ…
5842464530391591161390--
Notes And Loans Receivable Net Noncurrent
92-----------
Property Plant And Equipment And Finance Lease Rig…
158164164158181177170158150147140130
Intangible Assets Net Excluding Goodwill
706723739360154162174172142152163221
Goodwill
2392402401776161616161616161
Deferred Income Tax Assets Net
89109107138169170145151139150152134
Other Assets Noncurrent
625054363644464951555639
Assets
2,3472,2272,2762,1162,0551,9802,0501,9401,8311,6511,5221,338
Liabilities And Stockhold…
Liabilities Current
Long Term Debt Current
11111156511110
Accounts Payable Current
464366414535455038413739
Business Combination Contingent Consideration Liab…
---------000
Accounts Payable And Other Accrued Liabilities Cur…
286267251209202205174213199145139115
Liabilities Of Disposal Group Including Discontinu…
0222930-0------
Liabilities Current
333333347280248241784263237187177154
Asset Retirement Obligations Noncurrent
00001923232323232323
Long Term Debt And Capital Lease Obligations
5705695685675665651563562562561559
Deferred Income Tax Liabilities Net
545455--0------
Business Combination Contingent Consideration Liab…
737371--0------
Other Liabilities Noncurrent
1051081161025863626463636349
Liabilities
1,1341,1381,157949891892870913886835823785
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
111111111111
Additional Paid In Capital Common Stock
893888871845821818797776756758744730
Treasury Stock Common Value
-477-477-376-275-175-175-75-75-75-75-75-75
Retained Earnings Accumulated Deficit
79868062559851944645832726513430-102
Accumulated Other Comprehensive Income Loss Net Of…
-2-1-2-1-2-2-1-1-1-1-1-1
Stockholders Equity
1,2121,0901,1191,1671,1641,0881,1801,027946816699553
Liabilities And Stockholders Equity
2,3472,2272,2762,1162,0551,9802,0501,9401,8311,6511,5221,338
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
252525252525252525252525
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
250250250250250250250250250250250250
Common Stock Shares Issued
727272727271717171707070
Shares Outstanding
656572727268717171707070
Treasury Stock Common Shares
775422111111

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20269.12%20.66%15.19%---------
2025-6.12%1.24%-9.39%5.84%-2.43%8.08%9.65%24.25%25.74%1.33%11.12%24.50%
20240.05%1.18%49.39%2.22%4.98%11.31%-2.08%0.99%6.94%4.78%8.65%-12.88%
2023----9.16%-15.38%-4.72%10.71%-4.13%-14.61%-10.58%-6.55%16.86%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.83
2.70
2.67
4.29
5.74
5.52
1.65
4.68
4.84
5.80
5.37
4.88
Quick Ratio
2.64
2.51
2.49
4.07
5.46
5.23
1.56
4.41
4.55
5.45
5.05
4.55
Working Capital
609.12M
566.55M
578.25M
921.68M
1.18B
1.09B
511.64M
967.86M
911.60M
898.47M
771.83M
598.18M
Leverage & Debt
Debt to Equity
0.94
1.04
1.03
0.81
0.77
0.82
0.74
0.89
0.94
1.02
1.18
1.42
Interest Coverage TTM
14.64
15.74
17.63
22.25
23.07
23.23
24.44
23.17
24.17
18.21
3.16
2.04
Debt Ratio
0.48
0.51
0.51
0.45
0.43
0.45
0.42
0.47
0.48
0.51
0.54
0.59
Efficiency & Turnover
Asset Turnover TTM
0.70
0.73
0.71
0.75
0.79
0.84
0.84
0.88
0.86
0.87
0.92
0.96
Days Sales Outstanding TTM
83.14
80.49
81.41
85.07
81.49
72.05
71.76
79.77
77.44
70.06
69.10
71.92
Receivables Turnover TTM
4.39
4.53
4.48
4.29
4.48
5.07
5.09
4.58
4.71
5.21
5.28
5.07
Per Share Metrics
Diluted EPS TTM
4.24
3.41
2.48
3.85
3.56
4.36
5.85
6.07
6.57
4.65
1.49
0.47
Free Cash Flow Per Share TTM
5.83
5.25
6.16
6.99
6.89
7.13
6.51
5.69
4.05
3.79
3.79
3.58
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
60.48%
61.10%
62.23%
63.75%
64.04%
64.43%
64.78%
64.49%
64.02%
54.73%
53.65%
52.83%
Operating Profit Margin TTM
18.76%
20.16%
22.77%
28.78%
29.44%
29.79%
32.11%
31.93%
35.19%
28.13%
4.60%
2.57%
Net Profit Margin TTM
18.05%
15.15%
10.99%
17.82%
16.55%
20.37%
28.57%
29.80%
33.72%
25.20%
8.63%
2.97%
Growth Metrics
Net Revenue Growth (1Y)
0.62%
0.50%
1.95%
5.75%
12.53%
18.32%
24.15%
27.83%
32.98%
38.65%
50.43%
69.36%
Net Income Growth (1Y)
9.72%
-25.25%
-60.79%
-36.75%
-44.78%
-4.35%
310.79%
1,183.98%
-2,701.59%
1,063.86%
-2.75%
3.03%
EPS Growth (1Y)
16.39%
-23.35%
-59.48%
-35.98%
-44.71%
-5.64%
304.71%
1,165.74%
-2,663.45%
1,067.63%
-2.29%
3.49%
Valuation Metrics
P/E TTM
17.60
19.23
20.56
20.70
26.36
19.81
17.83
13.00
9.29
12.96
45.68
171.94
P/B TTM
4.05
4.12
3.08
4.81
5.76
5.69
6.46
5.42
4.53
5.19
6.80
10.38
P/S TTM
3.18
2.91
2.26
3.69
4.36
4.04
5.09
3.87
3.13
3.26
3.94
5.10
Market Cap
4.91B
4.49B
3.45B
5.61B
6.70B
6.19B
7.62B
5.57B
4.28B
4.23B
4.75B
5.74B
Enterprise Value
4.98B
4.70B
3.63B
5.48B
6.33B
5.84B
7.32B
5.38B
4.12B
4.08B
4.70B
5.88B
Calculated Values
Free Cash Flow TTM
377.11M
354.05M
414.02M
478.61M
473.01M
493.13M
451.98M
394.85M
278.34M
258.71M
259.12M
244.48M
Net Debt
70.11M
210.30M
185.10M
-129.62M
-373.37M
-348.23M
-302.72M
-192.96M
-156.72M
-152.79M
-54.47M
143.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-08-20Sale
Owner: Dapice, Joshua J., Gehani…
Title: -
Shares: 3,365,000
Price/Share: $56.15
Value: $188,944,750.00
Shares Owned: 3,477,227
Relationship: Other
Ownership: Indirect
2025-08-20Sale
Owner: Wehrly, Mark C, Roberts T…
Title: -
Shares: 3,365,000
Price/Share: $56.15
Value: $188,944,750.00
Shares Owned: 3,477,227
Relationship: Other
Ownership: Indirect
2025-08-13Sale
Owner: Blanchfield, Paul
Title: President
Shares: 3,060
Price/Share: $53.57
Value: $163,924.20
Shares Owned: 108,214
Relationship: Officer
Ownership: Direct
2025-06-13Sale
Owner: Niedzwiecki, Daniel
Title: See Remarks
Shares: 6,000
Price/Share: $78.74
Value: $472,440.00
Shares Owned: 87,057
Relationship: Officer
Ownership: Direct
2025-06-09Sale
Owner: Mchugh, Julie
Title: -
Shares: 5,192
Price/Share: $81.62
Value: $423,771.04
Shares Owned: 25,962
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
106.50%
Inst. Shares: 68,944,801
Shares Outstanding: 64,736,000
2025-12-31
108.18%
Inst. Shares: 73,011,515
Shares Outstanding: 67,489,000
2025-09-30
103.23%
Inst. Shares: 69,399,762
Shares Outstanding: 67,230,000
2025-06-30
112.54%
Inst. Shares: 77,105,346
Shares Outstanding: 68,516,000
2025-03-31
105.43%
Inst. Shares: 72,404,235
Shares Outstanding: 68,675,000

Lantheus Holdings, Inc. (LNTH) — SEC Financial Statements & Analysis

Lantheus Holdings, Inc. (LNTH) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Lantheus Holdings, Inc. trades on LNTH: Nasdaq as: LNTH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Lantheus Holdings, Inc. reported a 0.62% year-over-year revenue growth, a Gross Profit Margin of 60.48% (TTM), a Debt-to-Equity ratio of 0.94x, a Price-to-Sales (P/S) ratio of 3.18x (TTM), a Price-to-Book (P/B) ratio of 4.05 (TTM), at a market cap of $4.91B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
0.62%
Gross Profit Margin TTM
60.48%
Debt To Equity
0.94x
P/S TTM
3.18x
P/B TTM
4.05
Market Cap
$4.91B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lantheus Holdings, Inc. in?

Lantheus Holdings, Inc. (LNTH) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is LNTH's market cap?

Lantheus Holdings, Inc. (LNTH) has a market capitalization of $4.91B as of 2026-03-31.

What is LNTH's P/E ratio?

Lantheus Holdings, Inc. (LNTH)'s trailing twelve month P/E ratio is 17.60x as of 2026-03-31.

What exchange does LNTH trade on?

Lantheus Holdings, Inc. (LNTH) trades on the LNTH: Nasdaq.

Where is Lantheus Holdings, Inc. incorporated?

Lantheus Holdings, Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

Lantheus Holdings, Inc. (LNTH) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.